According to Cryo-Cell's latest financial reports the company's current EPS (TTM) is $0.30. In 2022 the company made an earnings per share (EPS) of $0.34 an increase over its 2021 EPS that were of $0.26.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.30 | -11.76% |
2022 | $0.34 | 30.77% |
2021 | $0.26 | -45.83% |
2020 | $0.48 | 65.52% |
2019 | $0.29 | -323.08% |
2018 | -$0.13 | -139.39% |
2017 | $0.33 | -265% |
2016 | -$0.20 | -122.99% |
2015 | $0.87 | 1640% |
2014 | $0.05000 | 1880.2% |
2013 | $0.002525 | -100.45% |
2012 | -$0.56 | 229.41% |
2011 | -$0.17 | -160.71% |
2010 | $0.28 | 115.38% |
2009 | $0.13 | -316.67% |
2008 | -$0.06000 | -86.05% |
2007 | -$0.43 | 79.17% |
2006 | -$0.24 | -366.67% |
2005 | $0.09000 | -64% |
2004 | $0.25 | -138.46% |
2003 | -$0.65 | 24.87% |
2002 | -$0.52 | -678.36% |
2001 | $0.09000 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Omnicell
OMCL | -$0.77 | -356.67% | ๐บ๐ธ USA |
Global Cord Blood CORBF | $0.64 | 114.07% | ๐ญ๐ฐ Hong Kong |
CorVel Corporation
CRVL | $4.36 | 1,353.33% | ๐บ๐ธ USA |